European Journal of Gynaecological Oncology
Print ISSN: 0392-2936 | Online ISSN: 2709-0086
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encouraged the submission of systematic reviews and meta-analyses.
Articles
Effectiveness and safety of traditional Chinese medicine for bone loss associated with endocrine therapy in patients with breast cancer: a systematic review and meta-analysis
Effectiveness and safety of traditional Chinese medicine for bone loss associated with endocrine therapy in patients with breast cancer: a systematic review and meta-analysis
DOI: 10.22514/ejgo.2024.002
Epithelial IL-8 immunostaining associated with overall survival in ovarian cancer
Epithelial IL-8 immunostaining associated with overall survival in ovarian cancer
DOI: 10.22514/ejgo.2024.003
Recombinant human IL-17D promotes the progression of human ovarian cancer SKOV3 cells and the expression of PD-L by activating the NF-κB pathway
Recombinant human IL-17D promotes the progression of human ovarian cancer SKOV3 cells and the expression of PD-L by activating the NF-κB pathway
DOI: 10.22514/ejgo.2024.004
Enhanced recovery after single-site robotic staging surgery of endometrial cancer
Enhanced recovery after single-site robotic staging surgery of endometrial cancer
DOI: 10.22514/ejgo.2024.005
Diagnostic value of dynamic enhanced multi-slice spiral CT in lymph node metastasis of cervical cancer and analysis of the causes of missed diagnosis
Diagnostic value of dynamic enhanced multi-slice spiral CT in lymph node metastasis of cervical cancer and analysis of the causes of missed diagnosis
DOI: 10.22514/ejgo.2024.006
Taraxasterol stimulates apoptosis of BCa cells via restraining PI3K/AKT and epidermal growth factor receptor (EGFR)
Taraxasterol stimulates apoptosis of BCa cells via restraining PI3K/AKT and epidermal growth factor receptor (EGFR)
DOI: 10.22514/ejgo.2024.007
Comparison of biopsy results between two groups of cytology-negative HPV 16/18 and other types of high-risk HPV positive patients
Comparison of biopsy results between two groups of cytology-negative HPV 16/18 and other types of high-risk HPV positive patients
DOI: 10.22514/ejgo.2024.008
The mechanism of miR-143-3p regulating FGF-9 in the proliferation, invasion
The mechanism of miR-143-3p regulating FGF-9 in the proliferation, invasion
DOI: 10.22514/ejgo.2024.009
Analysis of clinicopathological outcomes of atypical squamous cells that cannot exclude high-grade squamous intraepithelial lesions (ASC-H) in cervical cancer screening for women
Analysis of clinicopathological outcomes of atypical squamous cells that cannot exclude high-grade squamous intraepithelial lesions (ASC-H) in cervical cancer screening for women
DOI: 10.22514/ejgo.2024.010
The role of intraoperative consultation in the management of ovarian masses and endometrial carcinomas: a 7-year experience
The role of intraoperative consultation in the management of ovarian masses and endometrial carcinomas: a 7-year experience
DOI: 10.22514/ejgo.2024.011
Construction of a risk prediction model based on the analysis of MRI imaging features for patients with triple-negative breast cancer and validation of its efficacy
Construction of a risk prediction model based on the analysis of MRI imaging features for patients with triple-negative breast cancer and validation of its efficacy
DOI: 10.22514/ejgo.2024.012
Comparison between robotic and laparoscopic surgery in women over 65 years old with gynecological malignancies
Comparison between robotic and laparoscopic surgery in women over 65 years old with gynecological malignancies
DOI: 10.22514/ejgo.2024.013
CENPU affects the paclitaxel resistance of cervical cancer cells by regulating the FOXM1/ABCC5 pathway
CENPU affects the paclitaxel resistance of cervical cancer cells by regulating the FOXM1/ABCC5 pathway
DOI: 10.22514/ejgo.2024.014
Cancer screening behaviors and health literacy levels of women aged 30 and over in the northwest Turkey
Cancer screening behaviors and health literacy levels of women aged 30 and over in the northwest Turkey
DOI: 10.22514/ejgo.2024.015
Effects of docetaxel combined with radiotherapy on immune function, tumor marker indices, and suppression of gene inactivation in breast cancer patients
Effects of docetaxel combined with radiotherapy on immune function, tumor marker indices, and suppression of gene inactivation in breast cancer patients
DOI: 10.22514/ejgo.2024.016
Evaluation of colposcopy and LEEP results performed in gynecology and gynecological oncology surgery services
Evaluation of colposcopy and LEEP results performed in gynecology and gynecological oncology surgery services
DOI: 10.22514/ejgo.2023.071
Comparison of the diagnostic efficacy of DWI and DCE-MRI in depth of myometrial invasion, cervical invasion and FIGO staging in patients with endometrial cancer
Comparison of the diagnostic efficacy of DWI and DCE-MRI in depth of myometrial invasion, cervical invasion and FIGO staging in patients with endometrial cancer
DOI: 10.22514/ejgo.2024.017
Magnoflorine inhibits cisplatin-induced protective autophagy by down-regulating HMGB1 and increases drug sensitivity in drug-resistant ovarian cancer cells
Magnoflorine inhibits cisplatin-induced protective autophagy by down-regulating HMGB1 and increases drug sensitivity in drug-resistant ovarian cancer cells
DOI: 10.22514/ejgo.2024.018
Renal calyceal rupture with extensive urinoma formation as a complication of cervical cancer
Renal calyceal rupture with extensive urinoma formation as a complication of cervical cancer
DOI: 10.22514/ejgo.2024.019
Evaluation of AI-assisted colposcopy for detecting high-risk subtypes of human papillomavirus in CIN2
Evaluation of AI-assisted colposcopy for detecting high-risk subtypes of human papillomavirus in CIN2
DOI: 10.22514/ejgo.2024.020
Published Ahead of Print
Breast cancer screening outcomes and risk assessment among women of Abha city, Saudi Arabia
Breast cancer screening outcomes and risk assessment among women of Abha city, Saudi Arabia
Online publish date: 12 January 2024
DOI: 10.22514/ejgo.2024.001
Does coexistence of endometrial cancer and adenomyosis affect survival outcomes? A retrospective cohort study
Does coexistence of endometrial cancer and adenomyosis affect survival outcomes? A retrospective cohort study
Online publish date: 26 December 2023
DOI: 10.22514/ejgo.2023.112
Identification of a 3-cuproptosis-associated-lncRNA-signature that predicts the prognosis of endometrial cancer patients
Identification of a 3-cuproptosis-associated-lncRNA-signature that predicts the prognosis of endometrial cancer patients
Online publish date: 12 October 2023
DOI: 10.22514/ejgo.2023.073
Identification of an immune-related metabolic gene signature to predict possible prognosis in endometrial cancer and reveals immune landscape feature
Identification of an immune-related metabolic gene signature to predict possible prognosis in endometrial cancer and reveals immune landscape feature
Online publish date: 15 September 2023
DOI: 10.22514/ejgo.2023.072
Vulvar cancer in young woman—case report
Vulvar cancer in young woman—case report
Online publish date: 07 September 2023
DOI: 10.22514/ejgo.2023.070
Prognostic value of Ki-67 in patients with ovarian cancer
Prognostic value of Ki-67 in patients with ovarian cancer
Online publish date: 24 July 2023
DOI: 10.22514/ejgo.2023.051
Special Issues
Topic Collection "Current Novel Treatment of Patients with Ovarian Cancer"
Keywords: Ovarian Cancer, Epithelial Ovarian Cancer, Optimal Debulking Surgery, Chemotherapy HIPEC, Platinum-resistant Ovarian Cancer, Anti-angiogenesis, PARP Inhibitors
Editor: Samir A. Farghaly, MD, PhD,Scott M. Eisenkop, MD
Submission deadline: 31 December 2022
Breast Cancer
Keywords: Breast cancer;Systemic treatment;Adjuvant setting;Metastatic setting;Genetic councelling;Triple negative breast cancer;Her2+ Breast cancer;Endocrine treatment
Editor: Michael Friedrich, MD,Nicolò Bertozzi, MD
Submission deadline: 30 April 2022
Systematic Review or Meta-Analysis in Gynaecological Oncology
Keywords: Cervical cancer;Ovarian cancer;Uterine/endometrial cancer;Vulvar cancer;Vaginal cancer;Breast cancer;Gestational trophoblastic disease;Primary peritoneal cancer
Editor: Enrique Hernandez, MD
Submission deadline: 25 April 2022
Current Update in the Treatment of Cervical Cancer
Keywords: Radical hysterectomy; Fertility Sparing; Oncological Outcomes
Editor: Carlo Ronsini, MD
Submission deadline: 31 December 2024
Gynecological Cancer Prevention: A New Prospective
Keywords: Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology
Editor: Ottavia Dʼoria, MD
Submission deadline: 31 October 2023
Molecular Pathological Approach to Uterine Mesenchymal Tumors and Malignant Tumors for the Establishment of New Diagnostic and Therapeutic Methods
Keywords: Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer
Editor: Prof. Takuma Hayashi
Submission deadline: 31 October 2023
Molecular Characterization in Endometrial Cancer: Progress and Prospects
Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine
Editor: Andrea Giannini, MD, PhD
Submission deadline: 31 December 2022
Immunotherapy for Gynecological Oncology
Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer
Editor: Tadahiro Shoji, MD
Submission deadline: 31 July 2021
Enhanced Recovery of Gynecological Oncology
Keywords: Gynecological Cancer; Enhanced Recovery After Surgery; Minimally Invasive Surgery; Pain Management; Nutritional Support; High Quality Nursing; Psychological Counseling; Complication Management
Editor: Lin Li, MD
Submission deadline: 31 December 2022
Molecular Markers in Ovarian Cancer: Roles in Diagnosis, Prognostic Prediction, and Personalized Therapy
Keywords: Ovarian Cancer;Diagnosis;Prognosis;Treatment Response;Personalized Therapy;Platinum Resistance;Homologous Recombination Deficiency;Immunotherapy;Cytoreduction;Proteomics;Genomics;Prognostic Biomarkers;Diagnostic Biomarkers
Editor: Sharad Ghamande, MD,David Mysona, MD
Submission deadline: 30 March 2022
Featured Article
Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181
To Be a Reviewer
If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.
Review for EJGOJoin Editorial Board
You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.
Join Editorial BoardEditor-in-Chief
Prof. Enrique Hernandez, MD, FACOG, FACS.
Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.